Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |